Allostella 3G

Rx

Indications

• For the treatment of concomitant disease and sequelae due to impaired hepatic detoxification activity (e.g. in cirrhosis of the liver) with the symptoms of latent and manifest hepatic encephalopathy.

Dosage

• Adults: 1 – 2 sachets x 3 times daily.
• Children and adolescents: The experience on the use of the drug in children are limited.

Usage

• Allostella 3G is dissolved in plenty of fluid (e.g. a glass of water, tea or juice) and taken with or after meals.
• The ready-to-use solution is to be taken immediately after preparation.

• Hypersensitivity to L-ornithine L-aspartate or any of the excipients of the drug.
• Severe renal impairment (serum creatinine > 3 mg/100 ml).

Uncommon

• Nausea, vomiting, stomach ache, flatulence, diarrhea.

Very rare

• Pain in the limbs.

• Allostella 3G contains sorbitol. Patients with hereditary fructose intolerance (HFI) should not take/be given this medicinal product. Sorbitol may cause gastrointestinal discomfort and mild laxative effect.
• Allostella 3G contains azo colouring agent (sunset yellow) which may cause allergic reactions.
• Children and adolescents: No data are so far available on the use of the drug in children.
• Administration of Allostella 3G during pregnancy and lactation should therefore be avoided.
• As a result of the disease, the ability to drive and use machines may be impaired during treatment with L-ornithine L-aspartate.